THE TREATMENT OF ROCKY MOUNTAIN SPOTTED FEVER

Abstract

Supportive therapy has not been as effectively used in Rocky Mountain spotted fever as it might be. Several misconceptions, including the idea that intravenous fluids are harmful, have been allowed to remain unchallenged in the literature. Specific therapy with hyperimmune antiserum is not widely used as yet and is usually given too late to be of greatest benefit. Before its efficacy can be evaluated, basic supportive therapy must be better standardized. The usual treatment of the disease consists in general supportive measures and the relief of symptoms. It is true that poorly directed or unwisely chosen parenteral supportive therapy may prove harmful. Because parenteral therapy has been given to poor advantage in some cases, statements such as the following have been made: "In recent years, many physicians of wide experience with spotted fever have advised against transfusions and intravenous fluids. They have observed that patients receiving this type of treatment